Latest Breaking News On - Unified dyskinesia rating scale - Page 3 : comparemela.com

IRLAB Announces Top-Line Results from Phase IIb Trial of Mesdopetam (IRL790) in Parkinson s disease

IRLAB Announces Top-Line Results from Phase IIb Trial of Mesdopetam (IRL790) in Parkinson s disease
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Vastra gotalands lanRichard godfreyNicholas watersSerious adverse eventsChief executive officerFull analysis setUnified parkinsonDisease rating scaleMotor aspectsUnified dyskinesia rating scaleUnified dyskinesia ratings scaleIntegrative screening process

PharmaTher Announces Poster Presentation of Positive

Seeking guidance from FDA to proceed towards a Phase 3 clinical study of KETARX™ (ketamine) for Parkinson’s disease under the 505(b)(2) regulatory pathway .

San diego convention centerUnited statesSan diegoFabio chianelliCompany or pharmatherTrademark officePharmather holdings ltdNeither the canadian securities exchangeRegulation services providerUniversity of arizonaSociety for neuroscienceUnified dyskinesia rating scaleMother holdingsUnified parkinsonDisease rating scaleUnited states patent

PharmaTher Holdings Announces U S Patent Grant for Ketamine

The issuance of the US patent strengthens PharmaTher's intellectual property portfolio covering novel uses and dosage forms of ketamine

United statesFabio chianelliTrademark officePharmather holdings ltdCompany or pharmather phrrfphrmaUnified dyskinesia rating scalePharmather holdingsUnited states patentTreating motor disorders

PharmaTher Holdings Announces Grant of U S Patent Covering Ketamine for Parkinson s Disease

PharmaTher Holdings Announces Grant of U S Patent Covering Ketamine for Parkinson s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFabio chianelliMovement disordersCompany or pharmatherRisk factors in companyTrademark officePharmather holdings ltdInternational congressNeither the canadian securities exchangeRegulation services providerUniversity of arizonaFabio chianellichief executive officerpharmather holdings ltd telWall streetUnified dyskinesia rating scaleMother holdingsUnited states patent

PharmaTher Holdings Announces Grant of U S Patent Covering

Grant of US patent strengthens the PharmaTher’s intellectual property portfolio covering novel uses and delivery forms of ketamine Announced positive.

United statesFabio chianelliTrademark officeMovement disordersInternational congressPharmather holdings ltdCompany or pharmatherUniversity of arizonaUnified dyskinesia rating scaleMother holdingsUnited states patentTreating motor disordersUnified parkinsonDisease rating scaleLevodopa induced dyskinesiasCanadian stock exchange phrm cn